IN2015DN01727A - - Google Patents

Info

Publication number
IN2015DN01727A
IN2015DN01727A IN1727DEN2015A IN2015DN01727A IN 2015DN01727 A IN2015DN01727 A IN 2015DN01727A IN 1727DEN2015 A IN1727DEN2015 A IN 1727DEN2015A IN 2015DN01727 A IN2015DN01727 A IN 2015DN01727A
Authority
IN
India
Prior art keywords
composition
alopecia
treatment
preparing
finasteride
Prior art date
Application number
Inventor
Adrian Raffin Pohlmann
Denise Duarte Jornada
Silva Stanisçuaski Guterres
Original Assignee
Biolab Sanus Farmacêutica Ltda
Univ Fed Do Rio Grande Do Sul
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50182295&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2015DN01727(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biolab Sanus Farmacêutica Ltda, Univ Fed Do Rio Grande Do Sul filed Critical Biolab Sanus Farmacêutica Ltda
Publication of IN2015DN01727A publication Critical patent/IN2015DN01727A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/044—Suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/85—Polyesters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/654—The particulate/core comprising macromolecular material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Abstract

The present invention aims at providing a pharmaceutical composition for the treatment of alopecia the composition comprising polymeric nanoparticles preferably nanocapsules that contain finasteride pharmaceutically acceptable additives and carriers and also relates to the use of the nanoparticles for preparing the composition for the treatment of alopecia. The invention further includes a method for preparing finasteride nanocapsules suitable for a composition for topical application for the treatment of alopecia.
IN1727DEN2015 2012-08-31 2013-08-30 IN2015DN01727A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR102012022034-2A BR102012022034B1 (en) 2012-08-31 2012-08-31 FINASTERIDE POLYMERIC NANOPARTICLE, WATER SUSPENSION CONTAINING THE SAME, COMPOSITION FOR THE TREATMENT OF ALOPECIA, PROCESS OF PREPARATION OF THIS COMPOSITION, AND ITS USE
PCT/BR2013/000334 WO2014032151A1 (en) 2012-08-31 2013-08-30 Polymeric finasteride nanoparticle, aqueous composition containing same, composition for the treatment of alopecia, method for preparing said composition, and use thereof

Publications (1)

Publication Number Publication Date
IN2015DN01727A true IN2015DN01727A (en) 2015-05-29

Family

ID=50182295

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1727DEN2015 IN2015DN01727A (en) 2012-08-31 2013-08-30

Country Status (21)

Country Link
US (1) US9895302B2 (en)
EP (1) EP2891487B1 (en)
JP (1) JP6235018B2 (en)
KR (1) KR102128478B1 (en)
CN (1) CN104768539B (en)
AR (1) AR092402A1 (en)
AU (1) AU2013308355B2 (en)
BR (1) BR102012022034B1 (en)
CA (1) CA2883996C (en)
CL (1) CL2015000502A1 (en)
DK (1) DK2891487T3 (en)
ES (1) ES2702577T3 (en)
IN (1) IN2015DN01727A (en)
MX (1) MX357601B (en)
PE (2) PE20150731A1 (en)
SA (1) SA515360083B1 (en)
TR (1) TR201818992T4 (en)
UA (1) UA116993C2 (en)
UY (1) UY35003A (en)
WO (1) WO2014032151A1 (en)
ZA (1) ZA201501254B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2596720B1 (en) * 2015-07-10 2018-01-29 Juvilis Cosmetics S.L. Compositions for topical use
KR102429536B1 (en) * 2015-09-30 2022-08-04 (주)아모레퍼시픽 Thermostability suspension cosmetic composition
EP3426706A1 (en) 2016-03-08 2019-01-16 Living Proof, Inc. Long lasting cosmetic compositions
MY189759A (en) 2016-03-18 2022-03-02 Caregen Co Ltd Conjugate of finasteride with peptide
CN110325272A (en) * 2017-03-28 2019-10-11 富士胶片株式会社 Microcapsules and its manufacturing method
WO2018206077A1 (en) * 2017-05-08 2018-11-15 Merz Pharma Gmbh & Co. Kgaa Emulsion comprising finasteride
EP3681921A2 (en) 2017-09-13 2020-07-22 Living Proof, Inc. Color protectant compositions
JP7244495B2 (en) 2017-09-13 2023-03-22 リビング プルーフ インコーポレイテッド Long lasting cosmetic composition
CN110448525A (en) * 2018-05-08 2019-11-15 无锡派列博生物医药科技有限公司 A kind of external application Finasteride lipid nanometer preparation and preparation method thereof prevented hair loss with growth-promoting hair
KR102644611B1 (en) 2018-11-29 2024-03-07 (주)아모레퍼시픽 Composition for inhibiting hair loss or inflammation of skin
KR20200099901A (en) * 2019-02-15 2020-08-25 (주)인벤티지랩 Subcutaneous injection composition containing microparticles comprising finasteride
KR102157124B1 (en) * 2019-12-23 2020-09-18 (주)인벤티지랩 Sustained-release injectable compositions comprising finasteride
WO2021229578A1 (en) * 2020-05-13 2021-11-18 Follicle Pharma Ltd Compositions for delivery of bioactive agents into hair follicles
CA3193642A1 (en) * 2020-09-24 2022-03-31 Gary L. MADSEN Compositions and methods for the treatment of hair loss and other conditions
CN115400085A (en) * 2022-09-02 2022-11-29 南昌大学 Finasteride lipid vesicles and preparation method and application thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4900984B2 (en) * 1997-07-15 2012-03-21 武田薬品工業株式会社 Manufacturing method of sustained-release preparation
JP4939936B2 (en) * 2003-06-27 2012-05-30 株式會社アモーレパシフィック Method for producing self-assembling polymer nanoparticles containing physiologically active ingredients, and external preparation composition containing the obtained self-assembling polymer nanoparticles
WO2005000258A1 (en) 2003-06-27 2005-01-06 Amorepacific Corporation Self-assembled polymeric nanoparticles containing physiologically active ingredients and external application containing the nanoparticles
US20060204588A1 (en) 2005-03-10 2006-09-14 Elan Pharma International Limited Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof
US20080175807A1 (en) 2007-01-24 2008-07-24 Fujifilm Corporation Composition for hair
JP2009096787A (en) 2007-10-19 2009-05-07 Fujifilm Corp Water-dispersible nanoparticle including blood circulation promoter
FR2930176B1 (en) * 2008-04-18 2011-03-18 Univ Claude Bernard Lyon NOVEL PROCESS FOR THE PRODUCTION OF NANOCAPSULES, IN THE ABSENCE OF ORGANIC SOLVENT, AND NANOCAPSULES SO OBTAINED
HUE052571T2 (en) 2008-09-27 2021-05-28 Jina Pharmaceuticals Inc Lipid based pharmaceutical preparations for topical application
US20110195030A1 (en) 2008-10-15 2011-08-11 The University Of North Carolina At Chapel Hill Nanoparticle compositions comprising liquid oil cores
CN102423297B (en) * 2011-12-23 2013-11-20 厦门金达威集团股份有限公司 Self-microemulsion and preparation method thereof

Also Published As

Publication number Publication date
JP2015526483A (en) 2015-09-10
ES2702577T3 (en) 2019-03-04
EP2891487A1 (en) 2015-07-08
US9895302B2 (en) 2018-02-20
WO2014032151A1 (en) 2014-03-06
CL2015000502A1 (en) 2015-10-16
BR102012022034B1 (en) 2020-02-18
BR102012022034A2 (en) 2014-08-19
PE20191713A1 (en) 2019-12-05
EP2891487A4 (en) 2016-04-20
ZA201501254B (en) 2016-05-25
CA2883996A1 (en) 2014-03-06
PE20150731A1 (en) 2015-05-17
AU2013308355A1 (en) 2015-04-16
UA116993C2 (en) 2018-06-11
CN104768539B (en) 2019-03-05
CN104768539A (en) 2015-07-08
CA2883996C (en) 2020-10-27
AU2013308355B2 (en) 2017-08-31
JP6235018B2 (en) 2017-11-22
UY35003A (en) 2014-03-31
KR102128478B1 (en) 2020-07-01
KR20150046332A (en) 2015-04-29
DK2891487T3 (en) 2019-01-14
MX2015002299A (en) 2016-02-10
MX357601B (en) 2018-07-16
US20150238406A1 (en) 2015-08-27
AR092402A1 (en) 2015-04-22
SA515360083B1 (en) 2017-03-01
TR201818992T4 (en) 2019-01-21
EP2891487B1 (en) 2018-11-28

Similar Documents

Publication Publication Date Title
IN2015DN01727A (en)
IN2015DN01728A (en)
PH12016500953A1 (en) Tricyclic compounds as anticancer agents
MX2015010312A (en) Methods of treating melanoma.
PL2807159T3 (en) New indolizine derivatives, method for preparing same and pharmaceutical compositions containing them for the treatment of cancer
NZ702663A (en) Nuclear transport modulators and uses thereof
EP2827869A4 (en) Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
MX2014015004A (en) Benzo [c] isoxazoloazepine bromodomain inhibitors and uses thereof.
SG10201804817TA (en) Delayed release compositions of linaclotide
EP2897689A4 (en) Systems, compositions and methods for the treatment of alopecia
UA115357C2 (en) Pyridin-4-yl derivatives
EA032271B9 (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
EP2889287A4 (en) Dolastatin-10 derivative, method of producing same and anticancer drug composition containing same
EP2863897A4 (en) Nanoparticles of indirubin, derivatives thereof and methods of making and using same
MX366829B (en) Itraconazole compositions and dosage forms, and methods of using the same.
WO2015001163A3 (en) Lipid nanoparticles for healing wounds
BR112015027436A2 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
MX355719B (en) Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum.
MX2014014814A (en) Pharmaceutical composition for treating inflammation and pain.
MX2014014816A (en) Pharmaceutical composition for treating inflammation and pain.
IL229925A0 (en) Composition for the treatment of alopecia and method for producing thereof
IN2013CH03945A (en)
CA2864049A1 (en) Use of beta-nerve growth factor for inducing ovulation in mammals